A practical A-Z pocket manual that explains how to use drugs safely and effectively in an intensive care setting.
Numerous treatment options are available to intensive care staff; this requires detailed knowledge of routes of administration and contra-indications to use in certain clinical conditions. Now in its fourth edition, this concise, practical handbook to drugs and prescribing for intensive care gives up-to-date advice on established drugs as well as providing advice on those recently approved. The book is divided into two sections: an A-Z guide to many of the drugs available, with concise information on each drug, including uses, limitations, administration directions and adverse effects. The second section contains topics relevant to the critically ill patients, including factors that may affect drug prescribing and management of medical emergencies. There is also a key data section showing weight conversions, BMI and corresponding dosage calculations, and an invaluable chart indicating drug compatibility for IV administration. This is an invaluable resource for doctors, nurses, and pharmacists caring for critically ill patients.
Recenzijos
'The book is particulary strong on newer medicines and is stuffed full of useful pearls and snippets of information an excellent book that can act as a touchstone for frontline clinical pharmacists in critical care.' The Pharmaceutical Journal
Daugiau informacijos
A practical A-Z pocket manual that explains how to use drugs safely and effectively in an intensive care setting.
Introduction |
|
How to use this book |
|
Abbreviations |
|
x | |
Ackowledgements |
|
xiii | |
|
|
229 | (64) |
|
Routes of administrations |
|
|
231 | (2) |
|
|
233 | (1) |
|
|
233 | (1) |
|
|
234 | (1) |
|
|
235 | (1) |
|
|
235 | (1) |
|
Therapeutic durg monitoring |
|
|
236 | (1) |
|
Target range of concerntration |
|
|
237 | (1) |
|
Pharmacology inthe critically ill |
|
|
238 | (2) |
|
Cardiopulmonary resuscitation |
|
|
240 | (1) |
|
Drugs in advanced life support |
|
|
241 | (2) |
|
Management of acute major anaphylxis |
|
|
243 | (2) |
|
Management of severe hyperthermia |
|
|
245 | (2) |
|
Sedation, analgesia and neuromuscular blockade |
|
|
247 | (2) |
|
A practicalapproach to sedation and analgesiaz |
|
|
249 | (4) |
|
Management of status epilepticus |
|
|
253 | (1) |
|
Treatment of status epilepitcus |
|
|
253 | (2) |
|
Reasons for tretment failure |
|
|
255 | (1) |
|
|
256 | (1) |
|
Preventionof delerim termens and alcohol withdrawal syndrome |
|
|
257 | (1) |
|
Prevention of Wernikc-Korsakoff syndrome |
|
|
258 | (1) |
|
|
259 | (1) |
|
Inotroopes and vasopressors |
|
|
260 | (8) |
|
|
268 | (1) |
|
Immunonutrition in the ICU |
|
|
268 | (1) |
|
|
269 | (1) |
|
|
270 | (1) |
|
Bone marrow rescue following nitrous oxide |
|
|
270 | (1) |
|
|
271 | (1) |
|
Post-splenectomy prophylaxis |
|
|
272 | (2) |
|
|
274 | (4) |
|
|
278 | (1) |
|
Antibiotics: sensitivities |
|
|
279 | (2) |
|
Renal replacement therapy |
|
|
281 | (3) |
|
Extracorporeal drug clearnace; basic principles |
|
|
284 | (1) |
|
Drug doses inrenal failuer/renal replacement therapy |
|
|
285 | (5) |
|
Chemical pleurodesis of malignant pleural effusion |
|
|
290 | (3) |
|
|
293 | (24) |
|
Appendix A: Creatinine clearance |
|
|
395 | |
|
Appendix B: Weight conversion (stones/ib to kg) |
|
|
296 | (1) |
|
Appendix C: Body mas index (BMI) calculator |
|
|
297 | (1) |
|
Appendix D: Learnbody weight charts |
|
|
298 | (2) |
|
Appendix E: Infusion rate/dose calculation |
|
|
300 | (1) |
|
Appendix F: Drug compatibility chart |
|
|
301 | (1) |
|
Appendix G: Omeprazole administratoin record |
|
|
302 | (2) |
|
Appendix H: Drotrecogin prescribing criteria |
|
|
304 | (3) |
|
Appendix I: Drotrecogin administrations |
|
|
307 | (3) |
|
Appendix J: Drotrecogin administration record |
|
|
310 | (4) |
|
Appendix K: Vancomycin by continuous infusion |
|
|
314 | (2) |
|
Appendix L: Child-Pugh score |
|
|
316 | (1) |
Drug Index |
|
317 | |
Henry Paw is Consultant in Anaesthesia and Intensive Care, York Hospital and Honorary Senior Clinical Lecturer, York Medical School, York, UK. Rob Shulman is Lead Pharmacist, Critical Care, University College London Hospitals NHS Foundation Trust and Honorary Senior Lecturer, School of Pharmacy, University of London, London, UK.